The Latest Cardiac and Vascular News
MENLO PARK, Calif., Jan. 18, 2022 /PRNewswire/ — Ajax Health has announced the appointments of two of the most respected cardiovascular professionals to Cordis-X, an independent accelerator created to drive innovation and growth to Cordis. Cordis is a storied medical device brand with global reach that was acquired from Cardinal Health last […]
REDWOOD CITY, Calif., Jan. 18, 2022 (GLOBE NEWSWIRE) — HeartFlow Holding, Inc., the leader in revolutionizing precision heart care, today announced the appointment of Timothy Barabe to its Board of Directors. “We are honored to have an accomplished leader like Tim join the HeartFlow Board,” said William C. Weldon, Chairman of […]
Artivion to Host Investor & Analyst Day on March 23, 2022 ATLANTA, Jan. 18, 2022 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it was renaming and rebranding itself to Artivion, Inc., effective immediately. Derived from the words “aorta”, “innovation”, and […]
Preliminary Full Year 2021 Product Sales were approximately $40.1 million, including core non-COVID-19 sales growth of approximately 13% from 2020. Cumulative CytoSorb treatments surpassed 162,000. MONMOUTH JUNCTION, N.J., Jan. 18, 2022 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood […]
Niagara Falls, NY , Jan. 18, 2022 (GLOBE NEWSWIRE) — Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a nuclear medicine PET imaging company specializing in the field of cardiac Positron Emission Tomography (“PET”) imaging systems and clinical services, is pleased to announce today that the Company has entered into […]
– Elizabeth Tarka, M.D. appointed Chief Medical Officer – A. Brian Davis named Chief Financial Officer WAYNE, Pa.–(BUSINESS WIRE)–XyloCor Therapeutics, a clinical‑stage biopharmaceutical company developing novel gene therapies for cardiovascular disease, today announced that it has appointed Elizabeth Tarka, M.D. as Chief Medical Officer and A. Brian Davis as Chief […]
WASHINGTON–(BUSINESS WIRE)–CorVista Health, Inc., a digital health company dedicated to improving cardiovascular disease diagnosis, announces the appointment of Charles R. Bridges, M.D., Sc.D., as Executive Vice President and Chief Scientific Officer. In this role Charles will lead the scientific and clinical development of the CorVista System for commercialization. “We are […]
SALT LAKE CITY–(BUSINESS WIRE)–Foldax®, Inc. today announced the appointment of medical device veteran Scott Huennekens as an independent member of the company’s board of directors. Huennekens possesses more than 30 years of experience in the medical device industry, leading high-profile companies through IPOs and acquisitions, and serving on the board […]
GOTHENBURG, Sweden, Jan. 17, 2022 /PRNewswire/ — Getinge appoints Patricia Fitch as President North America Region. Patricia succeeds Eric Honroth who has been appointed President Life Science at Getinge. Patricia Fitch joined Getinge in March 2021 as Vice President US Sales covering the Acute Care Therapies division. Patricia has more than 30 years of medical device experience, having held leadership […]
GREENVILLE, S.C.–(BUSINESS WIRE)–Elastrin Therapeutics Inc., a privately held biotechnology company leveraging a platform technology to develop therapeutics that render calcified tissue and organs supple again, announced the formation of its Scientific Advisory Board. The Board is comprised of leading industry and university experts in cardiovascular research and clinical development. Former […]
